• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一名患有梗阻性肾病的前列腺癌患者的氟他胺和戈舍瑞林血清浓度:病例报告]

[Serum concentrations of flutamide and goserelin in a prostate cancer patient with obstructive nephropathy: a case report].

作者信息

Nagayoshi J, Higashi T, Maruyama Y

机构信息

Department of Urology, Matsusaka Chuo Hospital.

出版信息

Hinyokika Kiyo. 1999 Aug;45(8):543-6.

PMID:10500960
Abstract

A 72-year-old man presented with pollakiuria and dysuria. His prostate was the size of an apple and hard on digital rectal examination and the serum prostate specific antigen (PSA) level was 73 ng/ml (RIA). Ultrasonography revealed bilateral hydronephrosis and the serum creatinine level was 13.2 mg/dl. CT scanning of the abdomen demonstrated swelling of paraaortic lymph nodes. Transrectal needle biopsy of the prostate gave a diagnosis of moderately differentiated adenocarcinoma. Accordingly, the final diagnosis was prostate cancer (cT3N4M1, stage D2). Immediately after bilateral percutaneous nephrostomy, treatment with an LH-RH agonist (goserelin) and flutamide was commenced. Serum creatinine was 6.6 mg/dl at the start of antiandrogen therapy and decreased to 1.8 mg/dl after 27 days. A 125 mg flutamide capsule was administered at 7 a.m., and blood samples were collected 4 hours later on days 1, 2, 3, 5, 6, 8, 12, 14, 17, 18 and 27. The OH-flutamide concentration was measured. There was no significant correlation between serum creatinine and the OH-flutamide concentration. After implantation of goserelin (3.6 mg depot), blood samples were obtained at 11 a.m. on days 8, 12, 14, 15 and 25. The serum goserelin level was measured. The serum goserelin level increased to a peak on day 14, as described previously, but the peak value of 9.63 ng/ml was higher than that reported before (mean +/- SD 2.848 +/- 0.199).

摘要

一名72岁男性因尿频和排尿困难前来就诊。他的前列腺如苹果般大小,直肠指检时质地坚硬,血清前列腺特异性抗原(PSA)水平为73 ng/ml(放射免疫分析法)。超声检查显示双侧肾积水,血清肌酐水平为13.2 mg/dl。腹部CT扫描显示腹主动脉旁淋巴结肿大。经直肠前列腺穿刺活检诊断为中度分化腺癌。因此,最终诊断为前列腺癌(cT3N4M1,D2期)。在双侧经皮肾造瘘术后,立即开始使用促性腺激素释放激素(LH-RH)激动剂(戈舍瑞林)和氟他胺进行治疗。抗雄激素治疗开始时血清肌酐为6.6 mg/dl,27天后降至1.8 mg/dl。每天上午7点服用125 mg氟他胺胶囊,并在第1、2、3、5、6、8、12、14、17、18和27天4小时后采集血样,测定羟基氟他胺浓度。血清肌酐与羟基氟他胺浓度之间无显著相关性。在植入戈舍瑞林(3.6 mg长效制剂)后,于第8、12、14、15和25天上午11点采集血样,测定血清戈舍瑞林水平。血清戈舍瑞林水平在第14天升至峰值,如先前所述,但9.63 ng/ml的峰值高于之前报道的值(均值±标准差为2.848±0.199)。

相似文献

1
[Serum concentrations of flutamide and goserelin in a prostate cancer patient with obstructive nephropathy: a case report].[一名患有梗阻性肾病的前列腺癌患者的氟他胺和戈舍瑞林血清浓度:病例报告]
Hinyokika Kiyo. 1999 Aug;45(8):543-6.
2
[Giant prostate carcinoma treated effectively with endocrine therapy: case report].[内分泌治疗有效治疗巨大前列腺癌:病例报告]
Hinyokika Kiyo. 2007 Feb;53(2):133-5.
3
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer.加拿大一项多中心III期随机试验报告:针对临床局限性前列腺癌,在标准剂量放疗前进行3个月与8个月新辅助雄激素剥夺治疗的对比研究。
Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):15-23. doi: 10.1016/j.ijrobp.2004.02.022.
4
[A case of prostate cancer treated with combined androgen-blockade].[一例采用联合雄激素阻断治疗的前列腺癌病例]
Gan To Kagaku Ryoho. 2000 Feb;27(2):307-10.
5
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.评估调强放疗联合原位基因治疗加或不加激素治疗前列腺癌的I-II期试验——前列腺特异抗原反应及活检数据中期报告
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1520-9. doi: 10.1016/j.ijrobp.2003.09.083.
6
[Intermittent androgen deprivation treatment of prostate cancer restarted at low level of serum prostate specific antigen: a pilot study].[血清前列腺特异性抗原水平较低时重新开始间歇性雄激素剥夺治疗前列腺癌:一项试点研究]
Hinyokika Kiyo. 2001 Aug;47(8):553-5.
7
Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.氟他胺作为二线药物用于激素难治性前列腺癌最大雄激素阻断的效果。
Int J Urol. 2007 Mar;14(3):264-7. doi: 10.1111/j.1442-2042.2007.01681.x.
8
Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.前列腺特异性抗原半衰期与治疗前前列腺特异性抗原:延迟联合雄激素阻断治疗中前列腺特异性抗原变化趋势的关键预测因素
Int J Urol. 2007 Mar;14(3):192-6; discussion 197. doi: 10.1111/j.1442-2042.2007.01671.x.
9
Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.纪念斯隆凯特琳癌症中心前列腺癌新辅助激素治疗研究进展
Mol Urol. 2000 Fall;4(3):241-8;discussion 249-50.
10
Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.醋酸亮丙瑞林和醋酸戈舍瑞林在抑制前列腺癌患者血清睾酮水平方面具有等效且充分的效果。
BJU Int. 2008 May;101(9):1096-100. doi: 10.1111/j.1464-410X.2007.07374.x. Epub 2008 Jan 8.

引用本文的文献

1
No supra-additive effects of goserelin and radiotherapy on clonogenic survival of prostate carcinoma cells in vitro.戈舍瑞林与放疗对前列腺癌细胞体外克隆形成存活无超相加效应。
Radiat Oncol. 2007 Aug 26;2:31. doi: 10.1186/1748-717X-2-31.